PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Current methods to treat pain have several limitations (e.g., addiction, limited efficacy, etc.) and new options are sorely needed. Photobiomodulation (PBM) at 808 nm has been shown to reduce small fiber axon sensitivities in both human and animal models when applied for the purposes of action potential block. A study using a pulsed light dosing scheme was conducted to determine the viability of using commercially available IPGs for a potential implanted system. Results showed a reduction in pain lasting about 8 days, indicating that this method of delivery has promise for an implanted system.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Aaron Skubal, Andrew Buzza, Junqi Zhuo, Michael W. Jenkins, Michael Moffitt, "Evaluation of pulsatile photobiomodulation dosing via nerve cuff," Proc. SPIE PC12826, Mechanisms of Photobiomodulation Therapy XVIII, PC1282605 (13 March 2024); https://doi.org/10.1117/12.3002900